|Articles|February 5, 2008

New label approved to reflect Thrombin-JMI manufacturing changes

FDA approves revised labeling for Thrombin-JMI.

Enhanced processes to reduce Factor V light chain content to undetectable levels during the manufacture of

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!

Related Content